QQQ   415.91 (-1.77%)
AAPL   164.21 (-1.69%)
MSFT   398.88 (-1.33%)
META   483.13 (-3.72%)
GOOGL   153.17 (-1.82%)
AMZN   174.75 (-2.49%)
TSLA   148.59 (-0.89%)
NVDA   808.23 (-4.54%)
AMD   148.30 (-4.37%)
NIO   3.81 (-4.75%)
BABA   68.50 (-0.55%)
T   16.32 (-0.06%)
F   12.10 (+0.33%)
MU   106.98 (-4.42%)
GE   148.32 (-3.02%)
CGC   7.94 (+1.40%)
DIS   111.40 (-0.92%)
AMC   3.22 (+10.27%)
PFE   25.80 (+1.61%)
PYPL   61.81 (-0.47%)
XOM   119.97 (+1.22%)
QQQ   415.91 (-1.77%)
AAPL   164.21 (-1.69%)
MSFT   398.88 (-1.33%)
META   483.13 (-3.72%)
GOOGL   153.17 (-1.82%)
AMZN   174.75 (-2.49%)
TSLA   148.59 (-0.89%)
NVDA   808.23 (-4.54%)
AMD   148.30 (-4.37%)
NIO   3.81 (-4.75%)
BABA   68.50 (-0.55%)
T   16.32 (-0.06%)
F   12.10 (+0.33%)
MU   106.98 (-4.42%)
GE   148.32 (-3.02%)
CGC   7.94 (+1.40%)
DIS   111.40 (-0.92%)
AMC   3.22 (+10.27%)
PFE   25.80 (+1.61%)
PYPL   61.81 (-0.47%)
XOM   119.97 (+1.22%)
QQQ   415.91 (-1.77%)
AAPL   164.21 (-1.69%)
MSFT   398.88 (-1.33%)
META   483.13 (-3.72%)
GOOGL   153.17 (-1.82%)
AMZN   174.75 (-2.49%)
TSLA   148.59 (-0.89%)
NVDA   808.23 (-4.54%)
AMD   148.30 (-4.37%)
NIO   3.81 (-4.75%)
BABA   68.50 (-0.55%)
T   16.32 (-0.06%)
F   12.10 (+0.33%)
MU   106.98 (-4.42%)
GE   148.32 (-3.02%)
CGC   7.94 (+1.40%)
DIS   111.40 (-0.92%)
AMC   3.22 (+10.27%)
PFE   25.80 (+1.61%)
PYPL   61.81 (-0.47%)
XOM   119.97 (+1.22%)
QQQ   415.91 (-1.77%)
AAPL   164.21 (-1.69%)
MSFT   398.88 (-1.33%)
META   483.13 (-3.72%)
GOOGL   153.17 (-1.82%)
AMZN   174.75 (-2.49%)
TSLA   148.59 (-0.89%)
NVDA   808.23 (-4.54%)
AMD   148.30 (-4.37%)
NIO   3.81 (-4.75%)
BABA   68.50 (-0.55%)
T   16.32 (-0.06%)
F   12.10 (+0.33%)
MU   106.98 (-4.42%)
GE   148.32 (-3.02%)
CGC   7.94 (+1.40%)
DIS   111.40 (-0.92%)
AMC   3.22 (+10.27%)
PFE   25.80 (+1.61%)
PYPL   61.81 (-0.47%)
XOM   119.97 (+1.22%)
Free Trial
OTCMKTS:ACUR

Acura Pharmaceuticals (ACUR) Stock Price, News & Analysis

→ Explore the Future: Unlock the Top 3 AI Stocks for 2024 Report (From Darwin) (Ad)
Free ACUR Stock Alerts
$0.0028
0.00 (0.00%)
(As of 04/18/2024 ET)
Compare
Today's Range
$0.0028
▼
$0.0028
50-Day Range
N/A
52-Week Range
$0.00
▼
$0.05
Volume
163 shs
Average Volume
1,970 shs
Market Capitalization
$185,780.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest
ACUR stock logo

About Acura Pharmaceuticals Stock (OTCMKTS:ACUR)

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc. and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was formerly known as Halsey Drug Co., Inc. The company was incorporated in 1935 and is based in Palatine, Illinois. Acura Pharmaceuticals, Inc. operates as a subsidiary of Abuse Deterrent Pharma, LLC.

ACUR Stock Price History

ACUR Stock News Headlines

February 28, 2024 | benzinga.com
Acura Pharmaceuticals Stock (OTC:ACUR), Insider Trading Activity
February 10, 2024 | yahoo.com
Robert Kraft's foundation wants people to "stand up to hate" with Super Bowl ad
April 19, 2024 | Darwin (Ad)
2024's Must-Have Guide: Master Crypto Investment Today
The cryptocurrency revolution is here with Bitcoin soaring past the $70,000 milestone—a clear indicator of the booming digital currency market. Are you prepared to navigate these exciting yet complex waters? Introducing "Navigating the Future: A Comprehensive Guide to Cryptocurrency Investments in 2024." This free digital guide is your essential resource for understanding and capitalizing on cryptocurrency investments, tailored for both newcomers and seasoned investors. (**By clicking the link you are subscribing to The Conservative Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)
February 5, 2024 | msn.com
American Honda reports 10.3% Y/Y sales growth in January amid a sequential decline
January 13, 2024 | morningstar.com
Acura Pharmaceuticals Inc ACUR
November 20, 2023 | yahoo.com
Cumberland man jailed in alleged death threat against district court judge
September 26, 2023 | news.yahoo.com
Miami man distributed over $16 million of adulterated HIV drugs given to U.S. patients
August 24, 2023 | finance.yahoo.com
Acura Pharmaceuticals, Inc. (ACUR)
April 19, 2024 | Darwin (Ad)
2024's Must-Have Guide: Master Crypto Investment Today
The cryptocurrency revolution is here with Bitcoin soaring past the $70,000 milestone—a clear indicator of the booming digital currency market. Are you prepared to navigate these exciting yet complex waters? Introducing "Navigating the Future: A Comprehensive Guide to Cryptocurrency Investments in 2024." This free digital guide is your essential resource for understanding and capitalizing on cryptocurrency investments, tailored for both newcomers and seasoned investors. (**By clicking the link you are subscribing to The Conservative Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)
August 12, 2023 | forbes.com
Acura Extended Warranty Review: Everything You Need To Know
June 30, 2023 | au.finance.yahoo.com
ACUR - Acura Pharmaceuticals, Inc.
May 31, 2023 | msn.com
Got $1,000? 2 Amazing Growth Stocks That Could Help You Retire Richer
May 3, 2023 | marketwatch.com
Exploring the Growth Potential of the Opioid Drugs Market till 2031
April 27, 2023 | marketwatch.com
Azilsartan Medoxomil API Market Forecast to 2030
April 22, 2023 | thestreet.com
4 Stocks Under $10 Moving Higher
April 9, 2023 | benzinga.com
Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2023: One-Stop Source for Providing Real-Deal Information on Hundreds of Transactions
April 9, 2023 | marketwatch.com
Opioid Drugs Market Sales By 2030
March 29, 2023 | marketwatch.com
Calming and Sleeping Market Outlook and Forecast till 2028
March 13, 2023 | thestreet.com
Acura Stock Soars (ACUR)
February 17, 2023 | marketwatch.com
Opioid Drugs Market Forcast 2023 To 2028 : In-depth Research Analysis with Top Countries Data
February 13, 2023 | marketwatch.com
Azilsartan Medoxomil API Market 2023-2029 Global Forecast with Top Key Players such as: Takeda, Lupin, Acura Labs, Metrochem API
February 8, 2023 | marketwatch.com
Opioid Drugs Market Global Demand, Opportunities, Trends, Analysis and Forecast to 2028
January 25, 2023 | marketwatch.com
Analysis of Azilsartan Medoxomil API Market for the Period 2023 to 2028 : Development, Growth and Key Factors
January 5, 2023 | thestreet.com
Pfizer, Acura Painkiller Approved by FDA
September 4, 2022 | msn.com
Woman shot in face, hand in drive-by shooting on Queens street, 2 vehicles sought
August 18, 2022 | marketwatch.com
Calming and Sleeping Market Size and Growth 2022 Analysis Report by Manufactures, Trends, Share, Opportunity, Regions and Forecast to 2028
July 10, 2022 | morningstar.com
Acura Pharmaceuticals Inc - Stock Quote ACUR
See More Headlines
Receive ACUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acura Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2020
Today
4/19/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:ACUR
Previous Symbol
NASDAQ:ACUR
CUSIP
00509L70
CIK
786947
Web
www.acurapharm.com
Phone
(847) 705-7709
Fax
847-705-5399
Employees
9
Year Founded
1935

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$1.56 million
Price / Sales
0.12
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
66,350,000
Free Float
52,947,000
Market Cap
$185,780.00
Optionable
Not Optionable
Beta
1.89

Social Links

These 7 Stocks Will Be Magnificent in 2024 Cover
These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Robert B. Jones (Age 65)
    CEO, President & Director
    Comp: $150k
  • Mr. Peter A. Clemens (Age 71)
    Senior VP, CFO & Secretary
    Comp: $200k
  • Mr. Robert A. Seiser CPA (Age 60)
    Ph.D., VP, Treasurer & Corporate Controller
    Comp: $210.2k

Key Competitors

View All Competitors

ACUR Stock Analysis - Frequently Asked Questions

How have ACUR shares performed in 2024?

Acura Pharmaceuticals' stock was trading at $0.0001 at the start of the year. Since then, ACUR stock has increased by 2,700.0% and is now trading at $0.0028.
View the best growth stocks for 2024 here.

How were Acura Pharmaceuticals' earnings last quarter?

Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) issued its quarterly earnings results on Friday, February, 28th. The specialty pharmaceutical company reported $0.00 earnings per share for the quarter. The specialty pharmaceutical company had revenue of $1.32 million for the quarter.

What other stocks do shareholders of Acura Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acura Pharmaceuticals investors own include Denali Therapeutics (DNLI), Adamis Pharmaceuticals (ADMP), Ekso Bionics (EKSO), VIVUS (VVUS), Fulcrum Therapeutics (FULC), (GBSN) (GBSN), Trevena (TRVN), AcelRx Pharmaceuticals (ACRX), Allena Pharmaceuticals (ALNA) and Advanced Micro Devices (AMD).

How do I buy shares of Acura Pharmaceuticals?

Shares of ACUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Acura Pharmaceuticals have any subsidiaries?
The following companies are subsidiares of Acura Pharmaceuticals: Acura Pharmaceutical Technologies Inc..
Read More
This page (OTCMKTS:ACUR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
1970’s computer coder issues shocking A.I. warning
TradeSmith